PT Darya-Varia Laboratoria Tbk
IDX:DVLA.JK
1785 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,890,887.506 | 1,917,041.442 | 1,900,893.602 | 1,829,699.557 | 1,813,020.278 | 1,699,657.296 | 1,575,647.308 | 1,451,356.68 | 1,306,098.136 | 1,103,821.775 | 1,101,684.17 | 1,087,379.869 | 972,297.437 | 929,196.665 | 869,170.91 |
| Cost of Revenue
| 948,476.755 | 910,918.06 | 905,125.39 | 897,710.889 | 839,538.301 | 774,247.594 | 681,690.889 | 649,918.928 | 628,364.919 | 518,602.093 | 441,028.093 | 436,269.979 | 349,019.084 | 341,549.889 | 333,094.956 |
| Gross Profit
| 942,410.751 | 1,006,123.382 | 995,768.212 | 931,988.668 | 973,481.977 | 925,409.702 | 893,956.419 | 801,437.752 | 677,733.217 | 585,219.682 | 660,656.077 | 651,109.89 | 623,278.353 | 587,646.776 | 536,075.954 |
| Gross Profit Ratio
| 0.498 | 0.525 | 0.524 | 0.509 | 0.537 | 0.544 | 0.567 | 0.552 | 0.519 | 0.53 | 0.6 | 0.599 | 0.641 | 0.632 | 0.617 |
| Reseach & Development Expenses
| 30,658.194 | 25,013.285 | 40,300.245 | 26,303.077 | 23,668.051 | 23,172.448 | 24,158.361 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 96,152.125 | 83,257.725 | 73,926.947 | 71,240.669 | 54,749.669 | 54,015.003 | 57,069.681 | 125,797.244 | 133,205.786 | 107,800.052 | 109,234.252 | 97,578.979 | 89,493.149 | 79,875.792 | 90,766.429 |
| Selling & Marketing Expenses
| 334,572.182 | 398,842.248 | 380,851.94 | 322,101.059 | 333,687.767 | 343,600.927 | 363,386.969 | 472,688.284 | 426,190.902 | 380,215.834 | 403,986.18 | 366,223.366 | 390,755.957 | 370,682.132 | 325,981.349 |
| SG&A
| 762,076.436 | 482,099.973 | 454,778.887 | 393,341.728 | 388,437.436 | 397,615.93 | 420,456.65 | 598,485.528 | 559,396.688 | 488,015.886 | 513,220.432 | 463,802.345 | 480,249.106 | 450,557.924 | 416,747.778 |
| Other Expenses
| 12,288.279 | 1,062,616.243 | 310,709.378 | 308,333.749 | 267,948.371 | 11,147.006 | 8,416.117 | -132.305 | -536.419 | 3,098.486 | 8,102.129 | -8,858.321 | -17,148.491 | 12,383.895 | 1,901.405 |
| Operating Expenses
| 762,076.436 | 1,569,729.501 | 805,788.51 | 727,978.554 | 680,053.858 | 677,460.788 | 683,714.243 | 596,387.819 | 555,917.572 | 490,749.157 | 493,576.902 | 454,944.024 | 463,100.615 | 450,557.924 | 416,747.778 |
| Operating Income
| 180,334.315 | 198,347.376 | 208,602.035 | 210,716.106 | 296,623.723 | 267,309.717 | 219,966.023 | 203,632.359 | 126,738.358 | 94,470.525 | 167,079.175 | 196,165.866 | 160,177.738 | 137,088.852 | 119,328.176 |
| Operating Income Ratio
| 0.095 | 0.103 | 0.11 | 0.115 | 0.164 | 0.157 | 0.14 | 0.14 | 0.097 | 0.086 | 0.152 | 0.18 | 0.165 | 0.148 | 0.137 |
| Total Other Income Expenses Net
| 11,303.943 | 2,725.841 | 3,191.592 | 3,353.061 | 4,626.312 | 24,894.99 | 15,905.745 | 9,367.123 | 22,622.063 | 11,395.918 | 8,677.602 | 8,311.18 | 6,146.825 | 16,780.184 | -5,235.641 |
| Income Before Tax
| 191,638.258 | 201,073.217 | 211,793.627 | 214,069.167 | 301,250.035 | 272,843.904 | 226,147.921 | 214,417.056 | 144,437.708 | 105,866.443 | 175,756.777 | 204,477.046 | 166,324.563 | 153,869.036 | 114,092.535 |
| Income Before Tax Ratio
| 0.101 | 0.105 | 0.111 | 0.117 | 0.166 | 0.161 | 0.144 | 0.148 | 0.111 | 0.096 | 0.16 | 0.188 | 0.171 | 0.166 | 0.131 |
| Income Tax Expense
| 45,301.893 | 51,698.206 | 65,067.999 | 51,996.183 | 79,466.786 | 72,191.936 | 63,898.628 | 62,333.656 | 36,543.278 | 24,936.967 | 49,960.304 | 55,567.957 | 45,409.223 | 42,988.514 | 41,820.302 |
| Net Income
| 146,336.365 | 149,375.011 | 146,505.337 | 162,072.984 | 221,783.249 | 200,651.968 | 162,249.293 | 152,083.4 | 107,894.43 | 80,929.476 | 125,796.473 | 148,909.089 | 120,915.34 | 110,880.522 | 72,272.233 |
| Net Income Ratio
| 0.077 | 0.078 | 0.077 | 0.089 | 0.122 | 0.118 | 0.103 | 0.105 | 0.083 | 0.073 | 0.114 | 0.137 | 0.124 | 0.119 | 0.083 |
| EPS
| 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | 179.8 | 145 | 136 | 97 | 73 | 112 | 133 | 108 | 99 | 64 |
| EPS Diluted
| 130.66 | 133.37 | 130.81 | 144.71 | 198.24 | 179.8 | 145 | 136 | 97 | 73 | 112 | 133 | 108 | 99 | 64 |
| EBITDA
| 244,230.064 | 233,136.121 | 246,462.109 | 246,498.315 | 320,201.642 | 297,077.572 | 249,181.145 | 206,369.517 | 121,607.173 | 94,470.525 | 167,079.175 | 196,165.866 | 160,177.738 | 132,759.1 | 121,320.233 |
| EBITDA Ratio
| 0.129 | 0.122 | 0.13 | 0.135 | 0.177 | 0.175 | 0.158 | 0.142 | 0.093 | 0.086 | 0.152 | 0.18 | 0.165 | 0.143 | 0.14 |